The Appl1, Sortilin, and Syndecan-1 biomarker panel can depict either early atypical changes (flat/tufting HGPIN) or more advanced atypical changes (MP HGPIN/AIP). This evidence concerns the gene SDC1 and autoimmune pancreatitis.